Emisjoner, børsnoteringer m.m.

Offer document and acceptance form regarding Alexion Pharma Nordics Holding AB’s recommended public cash offer to shareholders in Wilson Therapeutics AB made public

(24.04.2018) DNB Markets is acting as Nordic financial adviser and settlement agent in connection with Alexion Pharma Nordics Holding AB recommended public cash offer to acquire all outstanding shares in Wilson Therapeutics AB at a price of SEK 232 per share.